Overview

High Dose IV Lidocaine vs Hydromorphone for Abdominal Pain in the Emergency Department

Status:
Recruiting
Trial end date:
2022-04-14
Target enrollment:
Participant gender:
Summary
Intravenous lidocaine will be given at a dose of 2 mg/kg intravenously to patients in the emergency department with a diagnosis of acute abdominal pain. Its efficacy will be compared to 1 mg of intravenous hydromorphone, with a primary endpoint of mean improvement of pain at 90 minutes.
Phase:
Phase 4
Details
Lead Sponsor:
Hennepin Healthcare Research Institute
Treatments:
Hydromorphone
Lidocaine